PAK6 and neoplasm: PAK6 is overexpressed in certain tumor types, including glioblastoma (Chang et al., 2024), triple-negative breast cancer (Pipili et al., 2024), prostate cancer (Liu et al., 2013), and myelodysplastic syndromes (Yao et al., 2024), suggesting its potential for distinguishing tumor tissue from normal tissue with high specificity.